IDEXX Laboratories, Inc. (IDXX) — Financial statements
Income statement, balance sheet, and cash flow for IDEXX Laboratories, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 4,304↑10.4% | 3,898↑6.5% | 3,661↑8.7% | 3,367↑4.7% | 3,215 | |
| Cost of Revenue | 1,644↑8.3% | 1,519↑3.2% | 1,471↑7.9% | 1,363↑2.8% | 1,326 | |
| Gross Profit | 2,660↑11.8% | 2,379↑8.6% | 2,190↑9.3% | 2,004↑6.1% | 1,889 | |
| Operating Expenses | ||||||
| R&D Expenses | 251↑14.3% | 220↑15.1% | 191↓25.1% | 255↑58.3% | 161 | |
| General & Administrative Expenses | 405↓8.5% | 442↑31.7% | 336↑2.9% | 326↑5.4% | 310 | |
| Selling & Marketing Expenses | 644↑9.4% | 589↑4.0% | 566↑7.9% | 525↑7.8% | 487 | |
| SG&A Expenses | 1,048↑1.7% | 1,031↑14.3% | 902↑6.0% | 851↑6.8% | 796 | |
| Other Expenses | 0.00 | 0.00 | 0.00↓100.0% | 2↑50.3% | 1 | |
| Operating Expenses | 1,300↑3.9% | 1,251↑14.4% | 1,093↓1.2% | 1,106↑15.5% | 957 | |
| Total Costs & Expenses | 2,944↑6.3% | 2,769↑8.0% | 2,564↑3.9% | 2,469↑8.1% | 2,283 | |
| Operating Results | ||||||
| Operating Income | 1,360↑20.5% | 1,128↑2.8% | 1,097↑22.1% | 899↓3.6% | 932 | |
| Depreciation & Amortization | 106↓18.1% | 130↑13.1% | 115↑2.7% | 112↑7.0% | 105 | |
| EBITDA | 1,469↑15.1% | 1,276↑4.8% | 1,218↑20.0% | 1,015↓2.4% | 1,040 | |
| EBIT | 1,362↑19.4% | 1,141↑3.5% | 1,103↑22.6% | 900↓3.5% | 932 | |
| Interest & Other Income | ||||||
| Net Interest Income | -36↓93.7% | -19↑48.5% | -36↑7.3% | -39↓32.1% | -29 | |
| Interest Income | 2↓80.9% | 13↑125.6% | 6↑428.5% | 1↑145.4% | 0.43 | |
| Interest Expense | 38↑22.6% | 31↓25.0% | 42↑4.3% | 40↑33.7% | 30 | |
| Non-Operating Income | -2↑80.9% | -13↓125.6% | -6↓428.5% | -1↓145.4% | -0.43 | |
| Other Income / Expenses | -36↓93.7% | -19↑48.5% | -36↑7.3% | -39↓32.1% | -29 | |
| Income Before Tax | 1,324↑19.3% | 1,110↑4.6% | 1,061↑23.4% | 860↓4.7% | 903 | |
| Income Tax Expense | 265↑19.3% | 222↑2.7% | 216↑19.5% | 181↑14.6% | 158 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 1,059↑19.3% | 888↑5.1% | 845↑24.4% | 679↓8.8% | 745 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 1,059↑19.3% | 888↑5.1% | 845↑24.4% | 679↓8.8% | 745 | |
| Bottom-Line Net Income | 1,059↑19.3% | 888↑5.1% | 845↑24.4% | 679↓8.8% | 745 | |
| EPS (Basic) | 13.17↑22.3% | 10.77↑5.9% | 10.17↑25.2% | 8.12↓7.1% | 8.74 | |
| EPS (Diluted) | 13.08↑22.6% | 10.67↑6.1% | 10.06↑25.3% | 8.03↓6.6% | 8.60 | |
| Weighted Average Shares | 80↓2.9% | 82↓0.7% | 83↓0.7% | 84↓1.9% | 85 | |
| Weighted Average Diluted Shares | 81↓3.1% | 83↓0.9% | 84↓0.7% | 85↓2.3% | 87 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.